Beckman/Nephromics in preeclampsia test pact
This article was originally published in Clinica
Executive Summary
Beckman Coulter has signed a licensing deal with Nephromics to develop laboratory tests for preeclampsia, the second leading cause of maternal deaths in the developed world.